Rantburg

Today's Front Page   View All of Fri 11/20/2026 View Thu 11/19/2026 View Wed 11/18/2026 View Tue 11/17/2026 View Mon 11/16/2026 View Sun 11/15/2026 View Sat 11/14/2026
2026-06-09 Science & Technology
STUDY on Off-label use of Ivermectin and Mebendazole in the treatment of cancer
[GeorgiaRecord] Recently, The Wellness Company announced a first of its kind human observational study of the off-label use of Ivermectin and Mebendazole in the treatment of cancer was published by the Anticancer Research Journal.

Dr. Peter McCullough, Chief Scientific Officer for The Wellness Company, and one of the authors of the manuscript, praised the results of this groundbreaking analysis. “In this first of its kind human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer. These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.”

The Anticancer Research Journal is a major international oncology journal of the International Institute of Anticancer Research - established in 1995.

Nicolas Hulscher, of the McCullough Foundation, emphasized just how ground-breaking this type of study is, “real world observational studies are incredibly important because they most accurately reflect how Ivermectin+Mebendazole are used in practical applications.”

The publication of this study makes it the largest peer-reviewed human study on the use of Ivermectin + Mebendazole in the treatment of cancer.

84% OF CANCER PATIENTS REPORTED A CLINICAL BENEFIT
In this human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer. These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.

The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6-months, participants reported an 84% Clinical Benefit Ratio. With 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression.

Cancer remains one of the leading causes of death globally, with conventional treatments such as chemotherapy, radiation therapy, and targeted agents frequently limited by significant toxicity, high cost, development of resistance, and variable long-term efficacy.

The experts at The Wellness Company undertook this study because ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited.

According to Dr. McCullough, “This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”

# id) ?>
Posted by NN2N1 2026-06-09 00:00|| E-Mail|| Front Page|| [1863 views ]  Top

1 
The more we read about Ivermectin's abilities. The more it raises questions why the US Medical Industrial Complex & Media fought so hard to discredit it uses.

Example:
Looking at India's living conditions vs USA raises a lot of questions of how our medical systems works?

In India, the cancer mortality rate is approx 6.31 per 1,000, while in the USA, it is about 8.63 per 1,000 ... or 33% more than India as of 2025.

Also India's overall death rate is approximately 7.53 per 1,000 people, while the USA's is about 9.28 deaths per 1,000 people as of 2025.






Posted by NN2N1 2026-06-09 05:53||   2026-06-09 05:53|| Front Page Top

2 Follow the money NN2N1. The "vaccine" was a clear moneymaker for the drug companies. Hospitals got compensated for COVID patients. Doctor got compensated for getting patients to take the shot.
The power hungry were able to control the population.

A cheap, effective solution upset their apple carts.
Posted by Warthog 2026-06-09 08:55||   2026-06-09 08:55|| Front Page Top

3 Lots of elderly culled from the herd as well.
Posted by Besoeker 2026-06-09 09:09||   2026-06-09 09:09|| Front Page Top

4 
Provisional COVID-19 Mortality Surveillance


Further down the page is also
Provisional COVID-19 Death Counts by Week Ending Date and State

It seems the CDC maybe quietly tracking C-19 related death and maybe the VAX relationships?
Posted by NN2N1 2026-06-09 10:16||   2026-06-09 10:16|| Front Page Top

Merry-Go-Blog










Paypal:
Google
Search WWW Search rantburg.com